Effectiveness of the Ileostomy Pathway in Reducing Readmissions for Dehydration: Does It Stand the Test of Time?


Journal

Diseases of the colon and rectum
ISSN: 1530-0358
Titre abrégé: Dis Colon Rectum
Pays: United States
ID NLM: 0372764

Informations de publication

Date de publication:
08 2020
Historique:
entrez: 22 7 2020
pubmed: 22 7 2020
medline: 19 12 2020
Statut: ppublish

Résumé

The ileostomy pathway, introduced in 2011, has proved to be successful in eliminating hospital readmissions for high-output ileostomy or dehydration in the following period of 7 months in a single institution. However, it is unclear whether this short-term success, immediately after the initiation of the program, can be sustainable in the long term. The aim of this study was to assess the efficacy and the durability of the ileostomy pathway in reducing readmissions for dehydration over a longer period of time. This was a retrospective review of the patients who entered into the ileostomy pathway, since its introduction on March 1, 2011, until January 31, 2015. This study was conducted at a tertiary academic center. Patients undergoing colorectal surgery with the creation of a new end or loop ileostomy were included. The long-term sustainability of the ileostomy pathway was assessed. The primary end point was readmission within 30 days after discharge for a high-output ileostomy or dehydration. A total of 393 patients (male n = 195, female n = 198, median age 52 (18-87) years) were included: 161 prepathway and 232 on-pathway. Overall 30-day postdischarge readmission rates decreased from 35.4% to 25.9% (p = 0.04). Readmissions due to high output and/or dehydration dropped from 15.5% to 3.9% (p < 0.001). Readmissions due to small-bowel obstructions dropped from 9.9% to 4.3%, (p = 0.03). The possible limitations of the study included a nonrandomized comparison of the patient groups and those patients who were possibly admitted to different institutions. The present ileostomy pathway decreases readmissions for high-output ileostomy and dehydration in patients with new ileostomies and is durable in the long term. See Video Abstract at http://links.lww.com/DCR/B233. EFICACIA DE VÍA DE ILEOSTOMÍA PARA REDUCIR LOS REINGRESOS POR DESHIDRATACIÓN: ¿RESISTE LA PRUEBA DEL TIEMPO?: La vía de ileostomía, introducida en 2011, ha demostrado ser exitosa en la eliminación de reingresos hospitalarios por ileostomía de alto rendimiento o deshidratación, por un período de 7 meses, en una sola institución. Sin embargo, no se ha aclarado si el éxito es a corto plazo, inmediatamente después del inicio del programa, y de que pueda ser sostenible a largo plazo.El objetivo de este estudio fue evaluar la eficacia y la durabilidad de la vía de ileostomía, para disminuir los reingresos por deshidratación, durante un período de tiempo más largo.Esta fue una revisión retrospectiva de pacientes que ingresaron a la vía de ileostomía, desde su introducción el 1 de marzo de 2011 hasta el 31 de enero de 2015.Este estudio se realizó en un centro académico terciario.Se incluyeron pacientes sometidos a cirugía colorrectal con la creación de una nueva ileostomía de extremo o asa.Evaluar la sostenibilidad de la vía de ileostomía a largo plazo.El punto final primario fue el reingreso dentro de los 30 días posteriores al alta, por una ileostomía de alto gasto o deshidratación.Se incluyeron un total de 393 pacientes (hombres n = 195, mujeres n = 198, edad media 52 [18-87] años), 161 antes de la vía y 232 en la vía. En general, las tasas de reingreso después del alta a 30 días, disminuyeron de 35.4% a 25.9% (p = 0.04). Los reingresos por alto rendimiento y / o deshidratación, disminuyeron del 15.5% al 3.9% (p < 0.001). Los reingresos debidos a obstrucciones del intestino delgado, disminuyeron del 9.9% al 4.3% (p = 0.03).Las posibles limitaciones del estudio incluyeron una comparación no aleatoria de los grupos de pacientes, y de aquellos pacientes que posiblemente fueron admitidos en diferentes instituciones.La vía de ileostomía disminuye los reingresos por ileostomía de alto gasto y deshidratación, en nuevos pacientes con ileostomía, y es duradera a largo plazo. Consulte Video Resumen en http://links.lww.com/DCR/B233.

Sections du résumé

BACKGROUND
The ileostomy pathway, introduced in 2011, has proved to be successful in eliminating hospital readmissions for high-output ileostomy or dehydration in the following period of 7 months in a single institution. However, it is unclear whether this short-term success, immediately after the initiation of the program, can be sustainable in the long term.
OBJECTIVE
The aim of this study was to assess the efficacy and the durability of the ileostomy pathway in reducing readmissions for dehydration over a longer period of time.
DESIGN
This was a retrospective review of the patients who entered into the ileostomy pathway, since its introduction on March 1, 2011, until January 31, 2015.
SETTINGS
This study was conducted at a tertiary academic center.
PATIENTS
Patients undergoing colorectal surgery with the creation of a new end or loop ileostomy were included.
INTERVENTION
The long-term sustainability of the ileostomy pathway was assessed.
MAIN OUTCOME MEASURES
The primary end point was readmission within 30 days after discharge for a high-output ileostomy or dehydration.
RESULTS
A total of 393 patients (male n = 195, female n = 198, median age 52 (18-87) years) were included: 161 prepathway and 232 on-pathway. Overall 30-day postdischarge readmission rates decreased from 35.4% to 25.9% (p = 0.04). Readmissions due to high output and/or dehydration dropped from 15.5% to 3.9% (p < 0.001). Readmissions due to small-bowel obstructions dropped from 9.9% to 4.3%, (p = 0.03).
LIMITATIONS
The possible limitations of the study included a nonrandomized comparison of the patient groups and those patients who were possibly admitted to different institutions.
CONCLUSIONS
The present ileostomy pathway decreases readmissions for high-output ileostomy and dehydration in patients with new ileostomies and is durable in the long term. See Video Abstract at http://links.lww.com/DCR/B233. EFICACIA DE VÍA DE ILEOSTOMÍA PARA REDUCIR LOS REINGRESOS POR DESHIDRATACIÓN: ¿RESISTE LA PRUEBA DEL TIEMPO?: La vía de ileostomía, introducida en 2011, ha demostrado ser exitosa en la eliminación de reingresos hospitalarios por ileostomía de alto rendimiento o deshidratación, por un período de 7 meses, en una sola institución. Sin embargo, no se ha aclarado si el éxito es a corto plazo, inmediatamente después del inicio del programa, y de que pueda ser sostenible a largo plazo.El objetivo de este estudio fue evaluar la eficacia y la durabilidad de la vía de ileostomía, para disminuir los reingresos por deshidratación, durante un período de tiempo más largo.Esta fue una revisión retrospectiva de pacientes que ingresaron a la vía de ileostomía, desde su introducción el 1 de marzo de 2011 hasta el 31 de enero de 2015.Este estudio se realizó en un centro académico terciario.Se incluyeron pacientes sometidos a cirugía colorrectal con la creación de una nueva ileostomía de extremo o asa.Evaluar la sostenibilidad de la vía de ileostomía a largo plazo.El punto final primario fue el reingreso dentro de los 30 días posteriores al alta, por una ileostomía de alto gasto o deshidratación.Se incluyeron un total de 393 pacientes (hombres n = 195, mujeres n = 198, edad media 52 [18-87] años), 161 antes de la vía y 232 en la vía. En general, las tasas de reingreso después del alta a 30 días, disminuyeron de 35.4% a 25.9% (p = 0.04). Los reingresos por alto rendimiento y / o deshidratación, disminuyeron del 15.5% al 3.9% (p < 0.001). Los reingresos debidos a obstrucciones del intestino delgado, disminuyeron del 9.9% al 4.3% (p = 0.03).Las posibles limitaciones del estudio incluyeron una comparación no aleatoria de los grupos de pacientes, y de aquellos pacientes que posiblemente fueron admitidos en diferentes instituciones.La vía de ileostomía disminuye los reingresos por ileostomía de alto gasto y deshidratación, en nuevos pacientes con ileostomía, y es duradera a largo plazo. Consulte Video Resumen en http://links.lww.com/DCR/B233.

Identifiants

pubmed: 32692076
doi: 10.1097/DCR.0000000000001627
pii: 00003453-202008000-00019
doi:

Types de publication

Journal Article Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Pagination

1151-1155

Références

Fish DR, Mancuso CA, Garcia-Aguilar JE, et al.Readmission after ileostomy creation: retrospective review of a common and significant event. Ann Surg. 2017;265:379–387.
Giannakopoulos GF, Veenhof AA, van der Peet DL, Sietses C, Meijerink WJ, Cuesta MAMorbidity and complications of protective loop ileostomy. Colorectal Dis. 2009;11:609–612.
Messaris E, Sehgal R, Deiling S, et al.Dehydration is the most common indication for readmission after diverting ileostomy creation. Dis Colon Rectum. 2012;55:175–180.
Paquette IM, Solan P, Rafferty JF, Ferguson MA, Davis BRReadmission for dehydration or renal failure after ileostomy creation. Dis Colon Rectum. 2013;56:974–979.
Richbourg L, Thorpe JM, Rapp CGDifficulties experienced by the ostomate after hospital discharge. J Wound Ostomy Continence Nurs. 2007;34:70–79.
Mols F, Lemmens V, Bosscha K, van den Broek W, Thong MSLiving with the physical and mental consequences of an ostomy: a study among 1-10-year rectal cancer survivors from the population-based PROFILES registry. Psychooncology. 2014;23:998–1004.
Turnbull GB, Erwin-Toth POstomy care: foundation for teaching and practice. Ostomy Wound Manage. 1999;45(suppl):23S–30S.
Bryant RAOstomy patient management: care that engenders adaptation. Cancer Invest. 1993;11:565–577.
Wick EC, Shore AD, Hirose K, et al.Readmission rates and cost following colorectal surgery. Dis Colon Rectum. 2011;54:1475–1479.
Nagle D, Pare T, Keenan E, Marcet K, Tizio S, Poylin VIleostomy pathway virtually eliminates readmissions for dehydration in new ostomates. Dis Colon Rectum. 2012;55:1266–1272.
Lacey J, Corbett J, Forni L, et al.A multidisciplinary consensus on dehydration: definitions, diagnostic methods and clinical implications. Ann Med. 2019;51:232–251.
Iqbal A, Sakharuk I, Goldstein L, et al.Readmission after elective ileostomy in colorectal surgery is predictable. JSLS. 2018;22:22.
Danielsen AK, Burcharth J, Rosenberg JPatient education has a positive effect in patients with a stoma: a systematic review. Colorectal Dis. 2013;15:e276–e283.
Migdanis A, Koukoulis G, Mamaloudis I, et al.Administration of an oral hydration solution prevents electrolyte and fluid disturbances and reduces readmissions in patients with a diverting ileostomy after colorectal surgery: a prospective, randomized, controlled trial. Dis Colon Rectum. 2018;61:840–846.
Iqbal A, Raza A, Huang E, Goldstein L, Hughes SJ, Tan SACost effectiveness of a novel attempt to reduce readmission after ileostomy creation. JSLS. 2017;21: e2016.00082.
Hardiman KM, Reames CD, McLeod MC, Regenbogen SEPatient autonomy-centered self-care checklist reduces hospital readmissions after ileostomy creation. Surgery. 2016;160:1302–1308.
Shaffer VO, Owi T, Kumarusamy MA, et al.Decreasing hospital readmission in ileostomy patients: results of novel pilot program. J Am Coll Surg. 2017;224:425–430.
Gonella F, Valenti A, Massucco P, et al.A novel patient-centered protocol to reduce hospital readmissions for dehydration after ileostomy. Updates Surg. 2019;71:515–521.
Chen SY, Stem M, Cerullo M, et al.Predicting the risk of readmission from dehydration after ileostomy formation: the dehydration readmission after ileostomy prediction score. Dis Colon Rectum. 2018;61:1410–1417.
Justiniano CF, Temple LK, Swanger AA, et al.Readmissions with dehydration after ileostomy creation: rethinking risk factors. Dis Colon Rectum. 2018;61:1297–1305.

Auteurs

Yu-Ting van Loon (YT)

Department of Surgery, Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands.
Department of Surgery, Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Vitaliy Y Poylin (VY)

Department of Surgery, Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Deborah Nagle (D)

Department of Surgery, Beth Israel Deaconess Medical Center, Boston, Massachusetts.

David D E Zimmerman (DDE)

Department of Surgery, Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH